ITT Investing Cash Flow decreased by 7332.2% to -$3.56B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 8646.9%, from -$40.70M to -$3.56B. Over 4 years (FY 2021 to FY 2025), Investing Cash Flow shows a downward trend with a 9.8% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$17.60M | -$19.20M | -$28.40M | -$29.40M | -$189.00M | -$26.40M | -$10.30M | -$28.50M | -$91.30M | -$22.20M | -$39.00M | -$435.30M | -$25.30M | -$334.00M | -$23.30M | -$40.70M | -$16.30M | -$14.90M | -$47.90M | -$3.56B |
| QoQ Change | — | -9.1% | -47.9% | -3.5% | -542.9% | +86.0% | +61.0% | -176.7% | -220.4% | +75.7% | -75.7% | <-999% | +94.2% | <-999% | +93.0% | -74.7% | +60.0% | +8.6% | -221.5% | <-999% |
| YoY Change | — | — | — | — | -973.9% | -37.5% | +63.7% | +3.1% | +51.7% | +15.9% | -278.6% | <-999% | +72.3% | <-999% | +40.3% | +90.7% | +35.6% | +95.5% | -105.6% | <-999% |